Lehman Financial Resources’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$1.68M Buy
21,703
+151
+0.7% +$11.4K 0.79% 25
2018
Q2
$1.53M Sell
21,552
-433
-2% -$30.6K 0.77% 26
2018
Q1
$1.66M Sell
21,985
-166
-0.7% -$13.2K 0.85% 26
2017
Q4
$1.59M Sell
22,151
-15,602
-41% -$1.18M 0.82% 25
2017
Q3
$3.06M Buy
+37,753
New +$2.89M 1.56% 24
2015
Q4
Sell
-250
Closed -$24K 165
2015
Q3
$24K Sell
250
-50
-17% -$5.55K 0.01% 225
2015
Q2
$35K Buy
300
+50
+20% +$5.46K 0.02% 190
2015
Q1
$25K Hold
250
0.01% 227
2014
Q4
$24K Hold
250
0.01% 216
2014
Q3
$27K Hold
250
0.01% 202
2014
Q2
$21K Hold
250
0.01% 227
2014
Q1
$18K Buy
+250
New +$19.6K 0.01% 236

Other funds holding GILD

Lehman Financial Resources's GILD Position: Q3 2018 in Review

Lehman Financial Resources increased its Gilead Sciences (GILD) stake by 0.7% in Q3 2018, buying an estimated $11.4K and bringing the position to 21,703 shares worth $1.68M. The position accounts for 0.79% of the portfolio, ranked #25.

Lehman Financial Resources first reported a position in GILD in Q1 2014 and has held it in 12 quarters since. The position peaked at $3.06M in Q3 2017. 1,527 funds tracked by Wall St. Rank hold GILD as of Q3 2018.

  • Lehman Financial Resources held 21,703 shares of Gilead Sciences worth $1.68M as of Q3 2018.
  • Lehman Financial Resources bought 151 Gilead Sciences shares in Q3 2018, an estimated $11.4K.
  • Gilead Sciences made up 0.79% of Lehman Financial Resources's portfolio in Q3 2018, its #25 holding.
  • Lehman Financial Resources first reported a position in Gilead Sciences in Q1 2014 and has held it in 12 quarters since.
  • Lehman Financial Resources's Gilead Sciences position peaked at $3.06M in Q3 2017.
  • 1,527 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2018.

Based on Lehman Financial Resources's 13F filing for Q3 2018, filed 14 Nov 2018.